000 01513 a2200433 4500
005 20250515131643.0
264 0 _c20080829
008 200808s 0 0 eng d
022 _a0004-4172
024 7 _a10.1055/s-0031-1296508
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aQuetglas, Emilio García
245 0 0 _aBioequivalence of two oral formulations of triflusal capsules in healthy volunteers.
_h[electronic resource]
260 _bArzneimittel-Forschung
_c2008
300 _a283-7 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aArea Under Curve
650 0 4 _aChemistry, Pharmaceutical
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aCross-Over Studies
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPlatelet Aggregation Inhibitors
_xadministration & dosage
650 0 4 _aReference Standards
650 0 4 _aSalicylates
_xadministration & dosage
650 0 4 _aSpectrometry, Fluorescence
650 0 4 _aSpectrophotometry, Ultraviolet
650 0 4 _aTherapeutic Equivalency
700 1 _aCampanero, Miguel Angel
700 1 _aSádaba, Belén
700 1 _aEscolar, Manuel
700 1 _aAzanza, Jose Ramón
773 0 _tArzneimittel-Forschung
_gvol. 58
_gno. 6
_gp. 283-7
856 4 0 _uhttps://doi.org/10.1055/s-0031-1296508
_zAvailable from publisher's website
999 _c18153120
_d18153120